The First-line Treatment of RCLM With RAS Mutation Was Local Short-course Radiotherapy (SCRT) + PD-1+ Standard Therapy
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to 5-Fluorouracil
Related studies linked through entity extraction aliases.
Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and Long-Term Rates of Organ Preservation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study Investigating the Efficacy and Safety of LBL-007 Plus Tislelizumab in Combination With Bevacizumab Plus Fluoropyrimidine Versus Bevacizumab Plus Fluoropyrimidine in Participants With Unresectable or Metastatic Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Intralesional 5-fluorouracil Injection for the Treatment of Oral Leukoplakia
- Status
- WITHDRAWN
- Phase
- PHASE1
A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Status
- RECRUITING
- Phase
- PHASE2
mFOLFOX6 Combined With Dalpiciclib in Patients With Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
SMART TNT for the Conservative Management of Locally Advanced Rectal Cancer
- Status
- RECRUITING
- Phase
- PHASE1
A Study to Compare Onivyde Manufactured at Two Different Production Sites in Adult Participants With Advanced Cancer in the Pancreas
- Status
- COMPLETED
- Phase
- PHASE1
A Study of AK112 With or Without AK117 in Metastatic Colorectal Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase I/II Study of the Combination of Irinotecan and POF (POFI) and Tislelizumab
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Adjuvant Trial in Patients With Resected PDAC Randomized to Allocation of Oxaliplatin- or Gemcitabine-based Chemotherapy by Standard Clinical Criteria or by a Transcriptomic Treatment Specific Stratification Signature
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Short-course Radiotherapy Followed by Consolidation Chemotherapy. 2021-001206-29
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Chinese Participants With Stage IV Colorectal Cancer (MK-3475-C66)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Phase Ib/II Study of AK112 in Combination With AK117 in Advanced Malignant Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic Gastric and Esophageal Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab, Standard Therapies, or Both, in Adults With Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)
- Status
- RECRUITING
- Phase
- PHASE1
ctDNA-Directed Post-Hepatectomy Chemotherapy for Patients With Resectable Colorectal Liver Metastases
- Status
- RECRUITING
- Phase
- PHASE2